Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend Regimens in Exudative Age-Related Macular Degeneration: 52- and 96-Week Findings from ALTAIR
2020 · Advances in Therapy · 245 citations
https://doi.org/10.1007/s12325-020-01236-x
A
Annabelle A. Okada
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
239
Papers
7.7K
Citations
49
h-index
136
i10-index
Annabelle A. Okada is an academic researcher from Kyorin University. The author has contributed to research in topics: Ocular Diseases and Behçet’s Syndrome & Retinal and Optic Conditions & Retinal Diseases and Treatments. The author has an h-index of 49, co-authored 204 publications.
ORCID: 0000-0002-8850-8962Papers by this author
worksEfficacy and Safety of Intravitreal Aflibercept Treat-and-Extend Regimens in Exudative Age-Related Macular Degeneration: 52- and 96-Week Findings from ALTAIR
2020 · Advances in Therapy · 245 citations
https://doi.org/10.1007/s12325-020-01236-x
Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic
2020 · Graefe s Archive for Clinical and Experimental Ophthalmology · 123 citations
https://doi.org/10.1007/s00417-020-04703-x
Three-month outcomes of faricimab loading therapy for wet age-related macular degeneration in Japan
2023 · Scientific Reports · 75 citations
https://doi.org/10.1038/s41598-023-35759-4
Pachychoroid: current concepts on clinical features and pathogenesis
2020 · Graefe s Archive for Clinical and Experimental Ophthalmology · 70 citations
https://doi.org/10.1007/s00417-020-04940-0
The Standardization of Uveitis Nomenclature Project
2013 · JAMA Ophthalmology · 45 citations
https://doi.org/10.1001/jamaophthalmol.2013.1596
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat